State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements

Background: In 2021, the Department of Health and Human Services released guidelines allowing waiver-eligible providers seeking to treat up to 30 patients to be exempt from waiver training (WT) and the counseling and other ancillary services (CAS) attestation. This study evaluates if states and the...

Full description

Bibliographic Details
Main Authors: Anita Silwal, Jeffery Talbert, Robert M. Bohler, Jordan Kelsch, Christopher Cook, Derek Blevins, Molly Gallivan, Timothy Hunt, Sarah M. Hatcher, Cindy Parks Thomas, Soncere Williams, Laura Fanucchi, Michelle R. Lofwall
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Buprenorphine
Data waiver
Policy
Opioid use disorder treatment
Treatment barriers
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724623000343

Internet

http://www.sciencedirect.com/science/article/pii/S2772724623000343

Similar Items